Who we are

Board of Directors

Agata Jakoncic
President Board PIF, Managing Director MSD Greece, Cyprus & Malta

As of January 2017, Agata has been leading MSD Greece, one of the top leading pharma companies in the Greek territory that is providing innovative medicines, vaccines and lifesaving therapies to patients.

Read more
George Tousimis
Board Vice President PIF, Country Director, Greece & Cyprus

Leading Amgen’s affiliate in Greece & Cyprus with a focus on challenging the status quo, fostering teamwork and delivering results. A believer in the value of pharma innovation and in the need for PIF to act visibly as its ambassador towards policy makers as well as the society, in order to improve patient access to innovative treatments in a sustainable manner.

Read more
Savas Charalampidis
Board Secretary PIF, General Manager of Gilead Sciences Hellas

Savas Charalampidis is the General Manager of Gilead Sciences Hellas, a subsidiary of Gilead Sciences, the US based biopharmaceutical Company with a mission to discover, develop and commercialize innovative therapeutics in the areas of unmet medical needs that improve patient care. He leads a team of passionate talents, committed to ensuring access and commercial success of Gilead’s disruptive innovation medicines.

Read more
Andreas Pollner
Paymaster Board PIF, Managing Director and Cluster CDH for Pharma in Greece, Cyprus, Bulgaria and Romania

Andreas Pollner (46 years old) joined Bayer Hellas as Managing Director and Cluster CDH for Pharma in Greece, Cyprus, Bulgaria and Romania by August 1st 2019. Andreas has a broad experience in the pharma market with Bayer in Business Coordination, Portfolio management, Sales & Marketing Management, as well as project assignments in the US.

Read more
Michaela Scheiffert
Board Member PIF, General Manager General Medicine Greece & Cyprus Member of BoD of Sanofi Greece & Cyprus Transformation Lead General Medicine MCO South Europe

Michaela Scheiffert joined Sanofi in 1997 successfully holding several positions in Sanofi, such as Marketing Director of the Cardiovascular Business Unit in Germany. After 10 years operating and leading teams in the in the cardiovascular business unit, Michaela moved in 2009 to the newly founded CHC department within Sanofi where she was leading the CHC Business in Germany since 2016.

Read more
Pascal Apostolides
Board Member, Managing Director, AbbVie Pharmaceuticals S.A.

Pascal Apostolides is the General Manager of the biopharmaceutical company AbbVie, former President of the Hellenic Association of Pharmaceutical Companies of Greece (SFEE) 2015-2018. He has been working in the medical field for 34 years, having held all positions of responsibility. He has studied Chemistry (B.Sc), Economic Geography (B.A.) and Pharmaceutical Chemistry (Grad.Diploma) in Canada, with a postgraduate degree in Environmental Chemistry (MSc) from the Department of Chemical Engineering, University of Stratchlyde in Glasgow.

Read more
Elena Chouliara
President & Managing Director ΑstraZeneca Greece & Cyprus, Member of the Board of Directors of PhRMA Innovation Forum

Elena Chouliara holds a degree in Law by the National and Kapodistrian University of Athens and an MBA by ALBA. She has proven experience in pharmaceutical industry and is appointed President and Managing Director of AstraZeneca Greece & Cyprus since December 2016.

Read more